Compare IBRX & MTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBRX | MTDR |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.3B |
| IPO Year | 2015 | 2011 |
| Metric | IBRX | MTDR |
|---|---|---|
| Price | $7.35 | $50.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | $12.57 | ★ $63.07 |
| AVG Volume (30 Days) | ★ 11.7M | 1.6M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $113,288,000.00 | ★ $3,696,277,000.00 |
| Revenue This Year | $88.59 | $7.15 |
| Revenue Next Year | $131.15 | $7.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 668.31 | 5.46 |
| 52 Week Low | $1.95 | $37.14 |
| 52 Week High | $12.43 | $66.84 |
| Indicator | IBRX | MTDR |
|---|---|---|
| Relative Strength Index (RSI) | 51.85 | 37.73 |
| Support Level | $6.69 | $40.78 |
| Resistance Level | $8.54 | $57.65 |
| Average True Range (ATR) | 0.40 | 1.74 |
| MACD | 0.04 | -0.31 |
| Stochastic Oscillator | 89.02 | 18.73 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream. The company generates majority of its revenue from the exploration and production segment.